Estados Unidos - inglés - NLM (National Library of Medicine)

baxter healthcare corporation - fibrinogen human (unii: n94833051k) (fibrinogen human - unii:n94833051k) - fibrinogen human 90 mg in 1 ml - hemostasis: tisseel is a fibrin sealant indicated for use as an adjunct to hemostasis in adult and pediatric patients (>1 month of age) undergoing surgery when control of bleeding by conventional surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical. tisseel is effective in heparinized patients. sealing: tisseel is a fibrin sealant indicated as an adjunct to standard surgical techniques (such as suture and ligature) to prevent leakage from colonic anastomoses following the reversal of temporary colostomies. do not inject tisseel directly into the circulatory system or into highly vascularized tissue. intravascular application of tisseel can lead to intravascular coagulation, can result in life-threatening thromboembolic events, and can increase the likelihood and severity of acute hypersensitivity reactions in susceptible patients ( see warnings and precautions (5.3 ) and adverse reactions (6.2) ). do not use tisseel in individuals with a known hypersensitivity to aproti

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - human fibrinogen; human thrombin; calcium chloride; aprotinin - solution for sealant - 4 ml - local hemostatics; tissue adhesives

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - human fibrinogen; human thrombin; calcium chloride; aprotinin - solution for sealant - 4 ml - local hemostatics; tissue adhesives

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - human fibrinogen; human factor xiii; aprotinin; human thrombin; calcium chloride - powder and solvent for sealant - . - local hemostatics; tissue adhesives

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - human fibrinogen; human factor xiii; aprotinin; human thrombin; calcium chloride - powder and solvent for sealant - . - local hemostatics; tissue adhesives

Kenia - inglés - Pharmacy and Poisons Board

human bioplazma llc h-2100 godollo transics milhaly ut 80hungary - human albumin - solution for infusion - 20%human albumin - blood substitutes and plasma protein fractions

Australia - inglés - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd - human thrombin, quantity: 800 iu - solution - excipient ingredients: water for injections; mannitol; sodium acetate; albumin; calcium chloride dihydrate; tributyl phosphate; octoxinol 9 - as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis. as suture support for haemostasis in large vessel vascular surgery. for suture line sealing in dura mater closure.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd - human thrombin, quantity: 4000 iu - solution - excipient ingredients: mannitol; calcium chloride dihydrate; water for injections; sodium acetate; albumin; tributyl phosphate; octoxinol 9 - ? as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis. ? as suture support for haemostasis in large vessel vascular surgery. ? for suture line sealing in dura mater closure.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd - human thrombin, quantity: 1600 iu - solution - excipient ingredients: water for injections; mannitol; sodium acetate; albumin; calcium chloride dihydrate; tributyl phosphate; octoxinol 9 - ? as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis. ? as suture support for haemostasis in large vessel vascular surgery. ? for suture line sealing in dura mater closure.

Singapur - inglés - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - clottable protein (human fibrinogen); human thrombin - solution - 50-90 mg/ml - clottable protein (human fibrinogen) 50-90 mg/ml; human thrombin 800-1200 iu/ml